Park Avenue Securities’s ICU Medical ICUI Stock Holding History

Park Avenue Securities’s Portfolio ICUI Stock Details ICUI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-1,149	Closed	-$215K	–	424
2019 Q4	$215K	Buy	+1,149	New	+$198K	0.01%	557

Other funds holding ICUI

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Nuance Investments Kansas City, Missouri $717M AUM 3.8% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Nitorum Capital New York $114M AUM 17.21% 1-Year Est. Return

Park Avenue Securities's ICUI Position: Q1 2020 in Review

Park Avenue Securities sold out of ICU Medical (ICUI) in Q1 2020, closing a stake of 1,149 shares — an estimated $215K sold.

Park Avenue Securities first reported a position in ICUI in Q4 2019 and held it in 1 quarter. The position peaked at $215K in Q4 2019. 272 funds tracked by Wall St. Rank hold ICUI as of Q1 2020.

Park Avenue Securities reported no remaining ICU Medical position as of Q1 2020 after selling out during the quarter.
Park Avenue Securities sold 1,149 ICU Medical shares in Q1 2020, an estimated $215K.
Park Avenue Securities first reported a position in ICU Medical in Q4 2019 and held it in 1 quarter.
Park Avenue Securities's ICU Medical position peaked at $215K in Q4 2019.
272 funds tracked by Wall St. Rank held ICU Medical as of Q1 2020.

Based on Park Avenue Securities's 13F filing for Q1 2020, filed 28 Apr 2020.